When Fast Means Faulty

od Furman, Richard R.
izdano v Gastroenterol Hepatol (N Y) (2020)

Current trends in the management of Richter's syndrome

od Allan, John N, Furman, Richard R
izdano v Int J Hematol Oncol (2019)

NK/T cell non-Hodgkin lymphoma in a HIV-positive patient

od Panarelli, Nicole C., Furman, Richard R., Wang, Y. Lynn, Elstrom, Rebecca, Cohen, Jules A., Chadburn, Amy
Izdano 2010

Extracorporeal Membrane Oxygenation as a Bridge to Chemotherapy in an Orthodox Jewish Patient

od Meltzer, Ellen C., Ivascu, Natalia S., Acres, Cathleen A., Stark, Meredith, Furman, Richard R., Fins, Joseph J.
Izdano 2014

Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease: A Clinical Pathology Conference held by the Department of Rheumatology at Hospital for Special Surgery

od Gordon, Jessica K., Magro, Cynthia, Lu, Theresa, Schneider, Robert, Chiu, April, Furman, Richard R., Solomon, Garron, Bass, Anne, Erkan, Doruk
Izdano 2009

Therapy of B-cell malignancies by anti–HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways

od Stein, Rhona, Gupta, Pankaj, Chen, Xiaochuan, Cardillo, Thomas M., Furman, Richard R., Chen, Susan, Chang, Chien-Hsing, Goldenberg, David M.
Izdano 2010

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia

od Islam Naziba, Broekman M Johan, Olson Kim E, Pulte Dianne, Ballard Harold S, Furman Richard R, Olson Ashley E, Marcus Aaron J
Izdano 2007-05-01

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia

od Pulte, Dianne, Olson, Kim E, Broekman, M Johan, Islam, Naziba, Ballard, Harold S, Furman, Richard R, Olson, Ashley E, Marcus, Aaron J
Izdano 2007

Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas

od Martin, Peter, Furman, Richard R., Rutherford, Sarah, Ruan, Jia, Ely, Scott, Greenberg, June, Coleman, Morton, Goldsmith, Stanley J., Leonard, John P.
izdano v Leuk Lymphoma (2015)

Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia

od Simon, Matthew S, Westblade, Lars F, Dziedziech, Alexis, Visone, Joseph E, Furman, Richard R, Jenkins, Stephen G, Schuetz, Audrey N, Kirkman, Laura A
izdano v Clin Infect Dis (2017)

Durable Responses with the Metronomic Regimen RT-PEPC in Elderly Patients with Recurrent Mantle Cell Lymphoma

od Ruan, Jia, Martin, Peter, Coleman, Morton, Furman, Richard R., Cheung, Ken, Faye, Adam, Elstrom, Rebecca, Lachs, Mark, Hajjar, Katherine A., Leonard, John P.
Izdano 2010

CD39 Expression on T Lymphocytes Correlates With Severity of Disease in Patients With Chronic Lymphocytic Leukemia

od Pulte, Dianne, Furman, Richard R., Broekman, M. Johan, Drosopoulos, Joan H. F., Ballard, Harold S., Olson, Kim E., Kizer, Jorge R., Marcus, Aaron J.
Izdano 2011

Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial

od Ghia, Paolo, Coutre, Steven E., Cheson, Bruce D., Barrientos, Jacqueline C., Hillmen, Peter, Pettitt, Andrew R., Zelenetz, Andrew D., Shreay, Sanatan, Hallek, Michael, Furman, Richard R.
izdano v Haematologica (2020)

Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor

od Vaisitti, Tiziana, Gaudino, Federica, Ouk, Samedy, Moscvin, Maria, Vitale, Nicoletta, Serra, Sara, Arruga, Francesca, Zakrzewski, Johannes L., Liou, Hsiou-Chi, Allan, John N., Furman, Richard R., Deaglio, Silvia
izdano v Haematologica (2017)

Evaluation of the CLL-IPI in Relapsed and Refractory Chronic Lymphocytic Leukemia in Idelalisib Phase 3 Trials

od Soumerai, Jacob D., Ni, Ai, Xing, Guan, Huang, Julie, Furman, Richard R., Jones, Jeffrey, Sharman, Jeffrey P., Hallek, Michael, Adewoye, Adeboye H., Dubowy, Ronald, Dreiling, Lyndah, Zelenetz, Andrew D.
izdano v Leuk Lymphoma (2018)

Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor

od Wierda, William G., Byrd, John C., Davids, Matthew S., Furman, Richard R., Cheson, Bruce D., Barr, Paul M., Eradat, Herbert, Heffner, Leonard, Zhou, Lang, Verdugo, Maria, Potluri, Jalaja, Choi, Michael
izdano v Br J Haematol (2018)

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

od Ruan, Jia, Martin, Peter, Shah, Bijal, Schuster, Stephen J., Smith, Sonali M., Furman, Richard R., Christos, Paul, Rodriguez, Amelyn, Svoboda, Jakub, Lewis, Jessica, Katz, Orel, Coleman, Morton, Leonard, John P.
izdano v N Engl J Med (2015)

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL and CD40L

od Cols, Montserrat, Barra, Carolina M., He, Bing, Puga, Irene, Xu, Weifeng, Chiu, April, Tam, Wayne, Knowles, Daniel M., Dillon, Stacey R., Leonard, John P., Furman, Richard R., Chen, Kang, Cerutti, Andrea
Izdano 2012

Ibrutinib Resistance in Chronic Lymphocytic Leukemia

od Furman, Richard R., Cheng, Shuhua, Lu, Pin, Setty, Menu, Perez, Alexendar R., Guo, Ailin, Racchumi, Joelle, Xu, Guozhou, Wu, Hao, Ma, Jiao, Steggerda, Susanne M., Coleman, Morton, Leslie, Christina, Wang, Y. Lynn
izdano v N Engl J Med (2014)

SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response

od Bologna, Cinzia, Buonincontri, Roberta, Serra, Sara, Vaisitti, Tiziana, Audrito, Valentina, Brusa, Davide, Pagnani, Andrea, Coscia, Marta, D’Arena, Giovanni, Mereu, Elisabetta, Piva, Roberto, Furman, Richard R., Rossi, Davide, Gaidano, Gianluca, Terhorst, Cox, Deaglio, Silvia
izdano v J Clin Invest (2015)